Related Experiment Video
Updated: Mar 27, 2026

11:08
Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
Published on: February 5, 2018
9.2K
Exploring architectures displaying multimeric presentations of a trihydroxypiperidine iminosugar
Camilla Matassini1, Stefania Mirabella1, Andrea Goti1
1Dipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy.
Beilstein Journal of Organic Chemistry
|January 7, 2016
Summary
Researchers synthesized novel multivalent dendrimers using click chemistry. These new trihydroxypiperidine-based structures show potential as α-fucosidase inhibitors, with preliminary biological investigations underway.
Area of Science:
- Carbohydrate Chemistry
- Medicinal Chemistry
- Supramolecular Chemistry
Background:
- α-fucosidase is a key enzyme in various biological processes, and its inhibitors are of therapeutic interest.
- Multivalent architectures can enhance the binding affinity and efficacy of bioactive molecules.
- Piperidine derivatives have shown promise as enzyme inhibitors.
Purpose of the Study:
- To synthesize novel multivalent architectures based on a trihydroxypiperidine α-fucosidase inhibitor.
- To explore the utility of click chemistry for constructing complex molecular architectures.
- To conduct a preliminary biological evaluation of the synthesized compounds against glycosidases.
Main Methods:
- Synthesis of tetravalent and nonavalent dendrimers using the copper azide-alkyne-catalyzed cycloaddition (CuAAC) reaction.
- Utilizing click chemistry to link terminal alkyne-bearing scaffolds with an azido-functionalized piperidine inhibitor.
- Preliminary biological assays against commercially available and human glycosidases.
Main Results:
- Successful synthesis of tetravalent and nonavalent dendrimeric structures.
- Demonstration of the click chemistry approach for creating multivalent inhibitors.
- Initial data on the inhibitory activity against selected glycosidases.
Conclusions:
- The study reports the successful synthesis of novel multivalent α-fucosidase inhibitors.
- Click chemistry provides an efficient route to these complex molecular architectures.
- Further investigation is warranted to fully elucidate the biological potential of these compounds.
Related Concept Videos
Oligosaccharide Assembly
3.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.8K
Dipeptidyl Peptidase 4 Inhibitors
1.0K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.0K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
384
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
384

